News
News Medical on MSN32m
Avelumab and cetuximab combination shows promise in phase II skin cancer trialA phase II clinical trial led by the Alliance for Clinical Trials in Oncology has met its primary endpoint, demonstrating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback